The advent of new and precise high-throughput screening technologies has opened up a vast resource for understanding the molecular mechanisms underlying disease, genetic disorders, and immune ...
Fast, local cryopreservation is a consistent bottleneck for autologous cell therapy developers, even in major cell and gene therapy hubs. For the peripheral blood mononuclear cells (PBMCs) that form ...